Laboratories 2020/2021 - Basic and Applied Immunology and Oncology

During the application process, candidates must select from 3 to 5 projects among ALL projects available for the PhD course.

5 PROJECT-BASED FELLOWSHIPS:

Project-Based Fellowship BAIO1

BRIGANTI ALBERTO

Unit: Urological Research Unit (URI)

BAIO1: Genomic alterations underlying immune escape mechanisms in prostate cancer:

Project-Based Fellowship BAIO2

DELLABONA PAOLO  

Unit: Experimental Immunology

BAIO2: Defining the metastatic immune contexture of colorectal cancer in the liver

Project-Based Fellowship BAIO4

IANNACONE MATTEO 

Unit: Dynamics of immune responses

BAIO4: Defining intrahepatic T cell priming events responsible for defective T cell responses

Project-Based Fellowship BAIO5

BIANCHI MARCO

Unit: Chromatin Dynamics

Establishing human mesothelioma organoids

 

BOLETTA ALESSANDRA - FCSR Fronzaroli

Unit: Molecular Basis of Cystic Kidney Disorders

Characterization of Key Metabolic Alterations in Renal Cell Carcinoma

BRENDOLAN ANDREA - FCSR Fronzaroli

Unit: Lymphoid Organ Development and Function

Role of fibroblastic stromal cells in lymphoid malignancies

CENCI SIMONE - FCSR Fronzaroli

Unit: Age Related Diseases

Mitohormesis in multiple myeloma

MONDINO ANNA - FCSR Fronzaroli

Unit: Lymphocyte Activation

Unlocking tumors to TCR/CAR engineered T cells

MONTI PAOLO - FCSR Fronzaroli

Unit: Transplant Immunology

Targeting the glucose transporter GLUT1 to control T cell activation

OSTUNI RENATO - FCSR Fronzaroli

Unit: Genomics of the innate immune system

Identification of immune suppressive pathways in liver metastatic cancer

TONON GIOVANNI - FCSR Fronzaroli

Unit: Functional Genomics of Cancer Unit

Single-cell genomic approaches to unravel tumor resistance

VAGO RICCARDO - FCSR Fronzaroli

Unit: Urological Research Institute

Analysis of long non-coding RNA altered in cancer progression

VENEREAU EMILIE - FCSR Fronzaroli

Unit: Chromatin Dynamics

Exploring HMGB1-directed strategies to fight cancer

VICENZI ELISA - FCSR Fronzaroli

Unit: Viral Pathogens and Biosafety

SARS-CoV-2 and COVID-19: drug repurposing and viral evolution